• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测非子宫内膜样子宫内膜癌患者总生存期列线图的开发与外部验证:一项基于人群的分析。

Development and external validation of a nomogram for predicting overall survival of patients with non-endometrioid endometrial cancer: A population-based analysis.

作者信息

Chen Jingya, Wang Xiaorong, Xu Qinfeng, Zhang Wei, Chen Hu, Gu Hailei, Tang Wenwei, Tian Ying, Wang Zhongqiu

机构信息

Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.

Taixing People's Hospital. Taizhou, China.

出版信息

Heliyon. 2024 Mar 29;10(7):e28864. doi: 10.1016/j.heliyon.2024.e28864. eCollection 2024 Apr 15.

DOI:10.1016/j.heliyon.2024.e28864
PMID:38596036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11002679/
Abstract

OBJECTIVES

The main objective of this study was to identify the key predictors and construct a nomogram that can be used to predict the overall survival of individuals with non-endometrioid endometrial cancer.

METHODS

A total of 2686 non-endometrioid endometrial cancer patients confirmed between 1988 and 2018 were selected from the Surveillance, Epidemiology, and End Results database. They were divided into a training cohort and an internal validation cohort. Independent risk factors were chosen by Cox regression analyses. A predictive nomogram model for overall survival was constructed based on above factors. A Chinese cohort of 41 patients was collected to be an external validation cohort.

RESULTS

Eight variables were estimated as independent predictors for overall survival. A nomogram was established using these factors. The -index for predicting the overall survival of patients with non-endometrioid endometrial cancer from the nomogram was 0.734, 0.700, and 0.767 in training, internal, and external validation cohort, respectively. Calibration plots and decision curve analysis showed that the nomogram was valuable for further clinical application.

CONCLUSION

We constructed a nomogram which can be used as an effective tool to predict the 3- and 5-year overall survival of Non-endometrioid endometrial cancer patients.

摘要

目的

本研究的主要目的是确定关键预测因素并构建一个列线图,用于预测非子宫内膜样子宫内膜癌患者的总生存期。

方法

从监测、流行病学和最终结果数据库中选取1988年至2018年间确诊的2686例非子宫内膜样子宫内膜癌患者。将他们分为训练队列和内部验证队列。通过Cox回归分析选择独立危险因素。基于上述因素构建总生存期的预测列线图模型。收集41例中国患者队列作为外部验证队列。

结果

八个变量被确定为总生存期的独立预测因素。使用这些因素建立了一个列线图。该列线图预测非子宫内膜样子宫内膜癌患者总生存期的C指数在训练队列、内部验证队列和外部验证队列中分别为0.734、0.700和0.767。校准图和决策曲线分析表明,该列线图对进一步的临床应用具有价值。

结论

我们构建了一个列线图,可作为预测非子宫内膜样子宫内膜癌患者3年和5年总生存期的有效工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/d2050a660d56/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/df997195c1ff/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/13e1a4a3730f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/c6f3cb9b9425/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/155cd698468b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/e7ddeccb66b5/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/efbffc387a4b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/d2050a660d56/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/df997195c1ff/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/13e1a4a3730f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/c6f3cb9b9425/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/155cd698468b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/e7ddeccb66b5/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/efbffc387a4b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5f/11002679/d2050a660d56/gr7.jpg

相似文献

1
Development and external validation of a nomogram for predicting overall survival of patients with non-endometrioid endometrial cancer: A population-based analysis.预测非子宫内膜样子宫内膜癌患者总生存期列线图的开发与外部验证:一项基于人群的分析。
Heliyon. 2024 Mar 29;10(7):e28864. doi: 10.1016/j.heliyon.2024.e28864. eCollection 2024 Apr 15.
2
Development and validation of a nomogram for predicting overall survival in patients with early-onset endometrial cancer.制定并验证预测早发性子宫内膜癌患者总生存期的列线图。
BMC Cancer. 2023 Dec 14;23(1):1230. doi: 10.1186/s12885-023-11682-9.
3
[Development and Evaluation of Prognostic Nomogram Model for Adult Ventricle Glioma Patients].[成人脑室胶质瘤患者预后列线图模型的建立与评估]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Jul;53(4):588-596. doi: 10.12182/20220760203.
4
Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.基于监测、流行病学和最终结果(SEER)数据库及外部验证队列的转移性非小细胞肺癌动态生存列线图的开发与验证
Transl Lung Cancer Res. 2022 Aug;11(8):1678-1691. doi: 10.21037/tlcr-22-544.
5
A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort.基于 SEER 数据库和中国队列的人群研究:用于预测接受外照射放射治疗的肝细胞癌患者总生存期的基于网络的列线图模型。
Front Endocrinol (Lausanne). 2023 Jan 31;14:1070396. doi: 10.3389/fendo.2023.1070396. eCollection 2023.
6
Construction of novel predictive tools for post-surgical cancer-specific survival probability in patients with primary chondrosarcoma and external validation in Chinese cohorts: a large population-based retrospective study.构建用于预测原发性软骨肉瘤患者术后癌症特异性生存概率的新型工具并在中国队列中进行外部验证:一项基于大人群的回顾性研究
J Cancer Res Clin Oncol. 2023 Nov;149(14):13027-13042. doi: 10.1007/s00432-023-05186-z. Epub 2023 Jul 19.
7
A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis.预测低级别子宫内膜间质肉瘤患者总生存期的列线图:基于人群的分析。
Cancer Commun (Lond). 2020 Jul;40(7):301-312. doi: 10.1002/cac2.12067. Epub 2020 Jun 18.
8
The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.基于 SEER 数据库和中国队列研究的列线图预测胰腺癌患者放疗后总生存的研究。
Front Endocrinol (Lausanne). 2023 Oct 25;14:1266318. doi: 10.3389/fendo.2023.1266318. eCollection 2023.
9
Construction and validation of a nomogram for predicting the prognosis of patients with lymph node-positive invasive micropapillary carcinoma of the breast: based on SEER database and external validation cohort.用于预测淋巴结阳性乳腺浸润性微乳头状癌患者预后的列线图的构建与验证:基于监测、流行病学和最终结果(SEER)数据库及外部验证队列
Front Oncol. 2023 Oct 24;13:1231302. doi: 10.3389/fonc.2023.1231302. eCollection 2023.
10
A Novel Clinical Nomogram for Predicting Cancer-Specific Survival in Adult Patients After Primary Surgery for Epithelial Ovarian Cancer: A Real-World Analysis Based on the Surveillance, Epidemiology, and End Results Database and External Validation in a Tertiary Center.一种预测上皮性卵巢癌成年患者初次手术后癌症特异性生存的新型临床列线图:基于监测、流行病学和最终结果数据库的真实世界分析及在三级中心的外部验证
Front Oncol. 2021 Apr 20;11:670644. doi: 10.3389/fonc.2021.670644. eCollection 2021.

本文引用的文献

1
MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer.磁共振成像评估的肿瘤与浆膜的无瘤距离可预测子宫内膜癌的肌层深部浸润及不良预后。
Insights Imaging. 2022 Jan 8;13(1):1. doi: 10.1186/s13244-021-01133-z.
2
Radiomic machine learning for pretreatment assessment of prognostic risk factors for endometrial cancer and its effects on radiologists' decisions of deep myometrial invasion.基于放射组学的机器学习对子宫内膜癌预后危险因素的术前评估及其对放射科医生判断深层肌层浸润的影响。
Magn Reson Imaging. 2022 Jan;85:161-167. doi: 10.1016/j.mri.2021.10.024. Epub 2021 Oct 20.
3
Histological Grade of Endometrioid Endometrial Cancer and Relapse Risk Can Be Predicted with Machine Learning from Gene Expression Data.
子宫内膜样子宫内膜癌的组织学分级和复发风险可通过机器学习从基因表达数据中进行预测。
Cancers (Basel). 2021 Aug 27;13(17):4348. doi: 10.3390/cancers13174348.
4
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.美国国立综合癌症网络(NCCN)指南见解:子宫肿瘤,2021年第3版
J Natl Compr Canc Netw. 2021 Aug 1;19(8):888-895. doi: 10.6004/jnccn.2021.0038.
5
Diffusion-weighted imaging versus dynamic contrast-enhanced imaging for pre-operative diagnosis of deep myometrial invasion in endometrial cancer: A meta-analysis.扩散加权成像与动态对比增强成像在子宫内膜癌术前诊断深层肌层浸润中的比较:一项荟萃分析。
Clin Imaging. 2021 Dec;80:36-42. doi: 10.1016/j.clinimag.2021.06.027. Epub 2021 Jul 1.
6
Immunotherapy in endometrial cancer: rationale, practice and perspectives.子宫内膜癌的免疫治疗:原理、实践与展望
Biomark Res. 2021 Jun 16;9(1):49. doi: 10.1186/s40364-021-00301-z.
7
Detection of deep myometrial invasion in endometrial cancer MR imaging based on multi-feature fusion and probabilistic support vector machine ensemble.基于多特征融合和概率支持向量机集成的子宫内膜癌磁共振成像中深层肌层浸润的检测。
Comput Biol Med. 2021 Jul;134:104487. doi: 10.1016/j.compbiomed.2021.104487. Epub 2021 May 11.
8
Comparison of survival outcomes and effects of therapy between subtypes of high-grade endometrial cancer - a population-based study.基于人群的研究:高级别子宫内膜癌各亚型生存结局和治疗效果的比较。
Acta Oncol. 2021 Jul;60(7):897-903. doi: 10.1080/0284186X.2021.1914347. Epub 2021 Apr 27.
9
Predictors of Survival in Women with High-Risk Endometrial Cancer and Comparisons of Sandwich versus Concurrent Adjuvant Chemotherapy and Radiotherapy.高危型子宫内膜癌患者生存预测因素分析及夹心式与同期辅助化疗联合放疗的比较。
Int J Environ Res Public Health. 2020 Aug 16;17(16):5941. doi: 10.3390/ijerph17165941.
10
Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.低剂量辅助阴道柱状施源器近距离放疗治疗早期非子宫内膜样型子宫内膜癌:复发风险和生存结局。
Int J Gynecol Cancer. 2020 Dec;30(12):1908-1914. doi: 10.1136/ijgc-2020-001623. Epub 2020 Jul 12.